J&J U.S. PHARMACEUTICAL SALES CLIMB 15.6% TO $496 MIL. IN FIRST QUARTER; SCHERING CLARITIN SALES ARE $130 MIL. IN FIRST NINE MONTHS ON U.S. MARKET
Executive Summary
Johnson & Johnson's domestic pharmaceutical sales rose 15.6% in the first three months of 1994 to $496 mil., the company reported April 28. The growth rate surpassed the 1993 first quarter increase of 11.1% for U.S. prescription drug sales.